Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40 subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through engagement of a novel receptor (IL-23R) on these cells. Recent analysis of the contribution of IL-12 and IL-23 to central nervous system autoimmune inflammation demonstrated that IL-23 rather than IL-12 was the essential cytokine. Using gene-targeted mice lacking only IL-12 (p35−/−) or IL-23 (p19−/−), we show that the specific absence of IL-23 is protective, whereas loss of IL-12 exacerbates collagen-induced arthritis. IL-23 gene-targeted mice did not develop clinical signs of disease and were completely resistant to the development of joint and bone pathology. Resistance correlated with an absence of IL-17–producing CD4+ T cells despite normal induction of collagen-specific, interferon-γ–producing T helper 1 cells. In contrast, IL-12–deficient p35−/− mice developed more IL-17–producing CD4+ T cells, as well as elevated mRNA expression of proinflammatory tumor necrosis factor, IL-1β, IL-6, and IL-17 in affected tissues of diseased mice. The data presented here indicate that IL-23 is an essential promoter of end-stage joint autoimmune inflammation, whereas IL-12 paradoxically mediates protection from autoimmune inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5. A model proposing the respective roles of IL-12/IFN-γ and IL-23 in T cell-priming events versus end-stage autoimmune inflammation. The precise mechanism through which IL-12/IFN-γ may down-regulate the magnitude of the inflammatory response (i.e., reducing IL-17 production) remains to be defined. It is recognized that IFN-γ may have dual roles during late-stage inflammation (i.e., antiinflammatory actions through termination of activated T cell responses [references 9, 29] while also stimulating macrophage function [reference 5]). a, The IL-23R is present on CD4+ CD45RBlo “memory” T cells (30), but this cell phenotype may also include activated CD4+ T cells that are not strictly memory T cells.](https://figures.cochat.ai/paper-figures/7aaa8df7955d4b7f85c0b7ac367626a2/divergent-pro-and-antiinflammatory-roles-for-il-23-and-il-12-in-joint-autoimmune-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Th17 cells, originally described in mice as being pathogenic in murine models of autoimmune disease [181, 182], have more recently been shown to protect against certain pathogens, including fungal infections [183].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Self-citationRapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183
Immunisation against heterologous type II collagen induces arthritis in mice
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025
Luster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., & Ramshaw, I. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3223 · Cited by 635
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., Chwalinska-Sadowska, H., & Maslinski, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2832 · Cited by 580 · cited 1×
“IL-17 is a potent proinflammatory cytokine produced by PBMCs/T cells and by cells isolated from synovial fluid of rheumatoid arthritis patients (27).”
BackgroundAccelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice
Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., & Matthys, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5507 · Cited by 458
Cited by
Items 901–1,000 of 1,001
Durrant, D. M., & Metzger, D. W. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.9 · Cited by 38
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Lindén, A. (2007) · Science's STKE · doi:10.1126/stke.3982007re4 · Cited by 35
Pappu, B. P., Angkasekwinai, P., & Dong, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.003 · Cited by 38
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses
Kim, B., Sarangi, P. P., Azkur, A. K., Kaistha, S. D., & Rouse, B. T. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.12.007 · Cited by 34
Bettencourt, B. F., Rocha, F. L., Alves, H., de Amorim, R. P., Caetano‐Lopes, J., Vieira‐Sousa, E., Pimentel-Santos, F. M., Lima, M. C. F., Porto, G., Branco, J., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/ket269 · Cited by 39
Expression of il-23/th17 pathway in a murine model of coxsackie virus b3-induced viral myocarditis
Yang, F., Wu, W., Yan, Y.-L., Pang, Y., Kong, Q., & Huang, Y. (2011) · Virology Journal · doi:10.1186/1743-422x-8-301 · Cited by 36
Ma, N., Yang, D., Okamura, H., Teramachi, J., Hasegawa, T., Qiu, L., & Haneji, T. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6041 · Cited by 38
Interleukin‐23 receptor polymorphism as a risk factor for oral cancer susceptibility
Chien, M., Hsin, C., Chou, L. S., Chung, T., Lin, C., Weng, M., Chou, M., Chen, M., & Yang, S. (2011) · Head & Neck · doi:10.1002/hed.21779 · Cited by 34
Su, Z., Lu, H., Jiang, Y., Zhu, H., Ze, L., Zhang, P., Ni, P., Shen, H., Xu, W., & Xu, H. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.09.037 · Cited by 34
Fitch, E., Rizzo, H. L., Kurtz, S. E., Wegmann, K. W., Gao, W., Benson, J., Hinrichs, D. J., & Blauvelt, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.88 · Cited by 34
IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis
Pöllinger, B. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0841-4 · Cited by 38
Novel Therapeutic Modalities to Address Nondrugable Protein Interaction Targets
Souza, E. B. D., Cload, S. T., Pendergrast, P. S., & Sah, D. W. Y. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.115 · Cited by 36
Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity
Kurts, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm800 · Cited by 45
Mohammadnezhad, L., Azgomi, M. S., Manna, M. P. L., Sireci, G., Rizzo, C., Badami, G. D., Tamburini, B., Dieli, F., Guggino, G., & Caccamo, N. (2022) · Cells · doi:10.3390/cells11101663 · Cited by 40
Preclinical development of AMG 139, a human antibody specifically targeting IL ‐23
Köck, K., Pan, W., Gow, J. M., Horner, M. J., Gibbs, J. P., Colbert, A., Goletz, T. J., Newhall, K. J., Rees, W. A., Sun, Y., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12904 · Cited by 36
Williams-Skipp, C., Raman, T., Valuck, R. J., Watkins, H. M., Palmer, B. E., & Scheinman, R. I. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24260 · Cited by 32
T Helper 17 Cells in Autoimmune Liver Diseases
Abe, M., Hiasa, Y., & Onji, M. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/607073 · Cited by 34
Brain energy metabolism and multiple sclerosis: progress and prospects
Park, S. J., & Choi, J. W. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01278-3 · Cited by 33
Blüml, S., Sahin, E., Saferding, V., Gonçalves‐Alves, E., Hainzl, E., Niederreiter, B., Hladik, A., Lohmeyer, T., Brunner, J. S., Bonelli, M. M., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0742-y · Cited by 33
Kim, T. H., Hong, J. M., Oh, B., Cho, Y. S., Lee, J., Kim, H., Lee, J.-E., Ha, M., Park, E. K., & Kim, S. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.4.418 · Cited by 32
Szalay, B., Mészáros, G., Cseh, Á., Ács, L., Deák, M., Kovács, L., Vásárhelyi, B., & Balog, A. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/808724 · Cited by 32
Interleukins and Cancer Immunotherapy
Yoshimoto, T., Morishima, N., Okumura, M., Chiba, Y., Xu, M., & Mizuguchi, J. (2009) · Immunotherapy · doi:10.2217/imt.09.46 · Cited by 36
IL-23: A Promising Therapeutic Target for Systemic Lupus Erythematosus
Leng, R., Pan, H., Chen, G.-M., Wang, C., Qin, W.-Z., Chen, L., Tao, J., & Ye, D. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.011 · Cited by 33
Canonigo-Balancio, A. J., Fos, C., Prod’homme, T., Bécart, S., & Altman, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902573 · Cited by 39
Interleukin-17A during Local and SystemicStaphylococcus aureus-Induced Arthritis in Mice
Henningsson, L., Jirholt, P., Lindholm, C., Eneljung, T., Silverpil, E., Iwakura, Y., Lindén, A., & Gjertsson, I. (2010) · Infection and Immunity · doi:10.1128/iai.00385-10 · Cited by 41
Immune Regulatory Genes Are Major Genetic Factors to Behcet Disease: Systematic Review
Deng, Y., Zhu, W., & Zhou, X. (2018) · The Open Rheumatology Journal · doi:10.2174/1874312901812010070 · Cited by 32
Defining the functional states of Th17 cells
Lee, Y., & Kuchroo, V. (2015) · F1000Research · doi:10.12688/f1000research.6116.1 · Cited by 31
Reasons for rarity of Th17 cells in inflammatory sites of human disorders
Annunziato, F., Santarlasci, V., Maggi, L., Cosmi, L., Liotta, F., & Romagnani, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.011 · Cited by 32
Revisiting the combinatorial potential of cytokine subunits in the IL-12 family
Detry, S., Składanowska, K., Vuylsteke, M., Savvides, S. N., & Bloch, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.026 · Cited by 36
TNF-α in T lymphocytes attenuates renal injury and fibrosis during nephrotoxic nephritis
Wen, Y., Rudemiller, N. P., Zhang, J., Robinette, T. J., Lu, X., Ren, J., Privratsky, J. R., Nedospasov, S. A., & Crowley, S. D. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00347.2019 · Cited by 33
Role of Co-stimulatory Molecules in T Helper Cell Differentiation
Schorer, M., Kuchroo, V. K., & Joller, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_6 · Cited by 33
The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment
Paroli, M., Spadea, L., Caccavale, R., Spadea, L., Paroli, M. P., & Nante, N. (2022) · Medicina · doi:10.3390/medicina58111552 · Cited by 39
Mangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., Ditto, N. T., Lin, Z., Yang, X., Cotter, P., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224246 · Cited by 33
Enzler, T., Gillessen, S., Dougan, M. L., Allison, J. P., Neuberg, D. S., Oble, D. A., Mihm, M. C., & Dranoff, G. (2007) · Blood · doi:10.1182/blood-2006-08-043786 · Cited by 31
Cells of the Immune System Orchestrate Changes in Bone Cell Function
Wythe, S. E., Nicolaidou, V., & Horwood, N. J. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9764-0 · Cited by 38
Lee, Y. H., Choi, S. J., Ji, J. D., & Song, G. G. (2011) · Inflammation Research · doi:10.1007/s00011-011-0398-2 · Cited by 34
Church, L. D., Filer, A. D., Hidalgo, E. R., Howlett, K. A., Thomas, A. M. C., Rapecki, S., Scheel‐Toellner, D., Buckley, C. D., & Raza, K. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3152 · Cited by 33
The role of Th1 and Th17 cells in glomerulonephritis.
Azadegan‐Dehkordi, F., Bagheri, N., Shirzad, H., & Rafieian‐Kopaei, M. (2015) · PubMed Central · doi:10.12860/jnp.2015.07 · Cited by 31
Waibler, Z., Kalinke, U., Will, J., Juan, M. H. S., Pfeilschifter, J. M., & Radeke, H. H. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.001 · Cited by 31
Dai, J., Liu, B., Cua, D. J., & Li, Z. (2007) · European Journal of Immunology · doi:10.1002/eji.200636643 · Cited by 31
Self-citationPlasticity and heterogeneity of Th17 in immune-mediated kidney diseases
Krebs, C. F., & Panzer, U. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.005 · Cited by 32
Kaushansky, N., Zhong, M., de Rosbo, N. K., Höftberger, R., Lassmann, H., & Ben‐Nun, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7364 · Cited by 33
The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases
Sherlock, J. P., Taylor, P. C., & Buckley, C. D. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000132 · Cited by 33
Loss of IL‐22 inhibits autoantibody formation in collagen‐induced arthritis in mice
Corneth, O. B. J., Reijmers, R. M., Mus, A. M. C., Asmawidjaja, P. S., van Hamburg, J. P., Papazian, N., Siegers, J. Y., Mourcin, F., Amin, R., Tarte, K., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546241 · Cited by 36
Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?
Wu, X., Wang, J., Liu, K., Zhu, J., & Zhang, H. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1086751 · Cited by 30
Li, H., Hsu, H.-C., Wu, Q., Yang, P., Li, J., Luo, B., Oukka, M., Steele, C. H., Cua, D. J., Grizzle, W. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms5259 · Cited by 31
Self-citationYang, P., Qiu, G., Wang, S., Su, Z., Chen, J., Wang, S., Kong, F., Lu, L., Ezaki, T., & Han, X. (2010) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2010.00899.x · Cited by 30
Oh, J. Y., Kim, M. K., Choi, H. J., Ko, J. H., Kang, E. J., Lee, H. J., Wee, W. R., & Lee, J. H. (2011) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2011.25.2.73 · Cited by 33
Knauer, J., Siegemund, S., Müller, U., Al‐Robaiy, S., Kastelein, R. A., Alber, G., & Straubinger, R. K. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00210.x · Cited by 30
Self-citationLFA-1 decreases the antigen dose for T cell activation in vivo
Wang, Y., Shibuya, K., Yamashita, Y., Shirakawa, J., Shibata, K., Kai, H., Yokosuka, T., Saito, T., Honda, S.-I., Tahara‐Hanaoka, S., et al. (2008) · International Immunology · doi:10.1093/intimm/dxn070 · Cited by 30
Ying-ying, G. U. O., Wang, N., Shuai, Z. H. A. O., Hou, L., Xu, Y., & Zhang, N. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20113093 · Cited by 29
Song, G. G., Bae, S., Choi, S. J., Ji, J. D., & Lee, Y. H. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1955-7 · Cited by 31
Th17 related cytokines in acute myeloid leukemia
Li, P., Ji, M., Park, J., Bunting, K. D., Ji, C., & Tse, W. (2012) · Frontiers in bioscience · doi:10.2741/4052 · Cited by 29
An emerging role of interleukin-23 in rheumatoid arthritis
Yuan, N., Yu, G., Liu, D., Wang, X., & Zhao, L. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1610429 · Cited by 31
IL-23 in arthritic and inflammatory pain development in mice
Lee, M.-C., Zhang, Z., Achuthan, A. A., Fleetwood, A. J., Smith, J. E., Hamilton, J. A., & Cook, A. D. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02212-0 · Cited by 30
Goettel, J. A., Algood, H. M. S., Olivares–Villagómez, D., Washington, M. K., Chaturvedi, R., Wilson, K. T., Kaer, L. V., & Polk, D. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.041 · Cited by 29
Uemura, Y., Liu, T.-Y., Narita, Y., Suzuki, M., Nakatsuka, R., Araki, T., Matsumoto, M., Iwai, L. K., Hirosawa, N., Matsuoka, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900873 · Cited by 30
Progress in Biological Sciences
Habibi, G., Norouzi, F., & Hajiboland, R. (2014) · Cited by 29
From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
Zaarour, N., Li, Y., Hui, S., Paul, B., & Chen, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.624632 · Cited by 38
Quiniou, C., Domínguez-Punaro, M. D. L. C., Cloutier, F., Erfani, A., Ennaciri, J., Sivanesan, D., Sanchez, M., Chognard, G., Hou, X., Rivera, J. C., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00540.2013 · Cited by 32
The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I
Vojdani, A., & Lambert, J. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep062 · Cited by 37
Venken, K., & Elewaut, D. S. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0507-2 · Cited by 31
Yu, P., Shen, F.-C., Zhang, X., Cao, R., Zhao, X., Liu, P., Tu, H., Yang, X., Shi, R., & Zhang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044380 · Cited by 29
Dankers, W., González-Leal, C., Davelaar, N., Asmawidjaja, P. S., Mus, A. M. C., Hazes, J. M. W., Colin, E. M., & Lubberts, E. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1706-9 · Cited by 30
Nakayama, T., Yoshimura, M., Higashioka, K., Miyawaki, K., Ota, Y., Ayano, M., Kimoto, Y., Mitoma, H., Ono, N., Arinobu, Y., et al. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104263 · Cited by 30
Pathogenesis-oriented therapy of psoriasis using biologics
Boehncke, W., & Brembilla, N. C. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2100219 · Cited by 32
Li, L., Feng, X., Tao, M.-T., Paulsen, B. S., Huang, C., Feng, B., Liu, W., Yin, Z., Song, X., Zhao, X., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.992102 · Cited by 37
The interleukin 23 receptor gene in multiple sclerosis: A case-control study
Roos, I. M., Kockum, I. S., & Hillert, J. A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.011 · Cited by 33
Carrión, M., Pérez‐García, S., Jimeno, R., Juarranz, Y., González‐Álvaro, I., Pablos, J. L., Gutiérrez‐Cañas, I., & Gomariz, R. P. (2013) · NeuroImmunoModulation · doi:10.1159/000350892 · Cited by 31
Role of TH-17 Cells in Rheumatic and Other Autoimmune Diseases
Volin, M. V., & Shahrara, S. (2011) · Rheumatology Current Research · doi:10.4172/2161-1149.1000104 · Cited by 30
Wallis, S. K., Cooney, L. A., Endres, J., Lee, M. J., Ryu, J. H., Somers, E. C., & Fox, D. A. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3239 · Cited by 28
Cytokine targeting in rheumatoid arthritis
Bui, V. L., & Brahn, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.04.001 · Cited by 31
Induction of Immunity and Inflammation by Interleukin-12 Family Members
Alber, G., Al‐Robaiy, S., Kleinschek, M. A., Knauer, J., Krumbholz, P., Richter, J., Schoeneberger, S., Schütze, N., Schulz, S. M., Toepfer, K., et al. (2006) · Springer eBooks · doi:10.1007/3-540-37673-9_7 · Cited by 34
Keino, H., Watanabe, T., Sato, Y., Niikura, M., Wada, Y., & Okada, A. A. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2530 · Cited by 28
Carregaro, V., Sá‐Nunes, A., Cunha, T. M., Grespan, R., Oliveira, C. J. F., Lima-Junior, D. S., Costa, D. L., Verri, W. A., Jr., Milanezi, C. M., Pham, V. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003404 · Cited by 31
The interleukin-12 family of cytokines: Therapeutic targets for inflammatory disease mediation
Barrie, A. M., & Plevy, S. E. (2005) · Clinical and Applied Immunology Reviews · doi:10.1016/j.cair.2005.06.003 · Cited by 34
Özen, G., Deniz, R., Eren, F., Erzık, C., Unal, A. U., Yavuz, Ş., Aydın, S. Z., İnanç, N., Di̇reskeneli̇, H., & Atagündüz, P. (2017) · The Open Rheumatology Journal · doi:10.2174/1874312901711010001 · Cited by 27
Personalised Medicine with IL-23 Blockers: Myth or Reality?
Gottlieb, Z. S., & Sands, B. E. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab190 · Cited by 30
Yoshiga, Y., Goto, D., Segawa, S., Horikoshi, M., Hayashi, T., Matsumoto, I., Ito, S., Taniguchi, M., & Sumida, T. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04369.x · Cited by 27
Azreq, M.-A. E., Boisvert, M., Césaro, A., Pagé, N., Loubaki, L., Allaeys, I., Chakir, J., Poubelle, P. E., Tessier, P. A., & Aoudjit, F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301940 · Cited by 28
T-helper cells in the etiopathogenesis of periodontal disease: A mini review
Talwar, A., Arun, K., & Kumar, T. S. S. (2011) · Journal of Indian Society of Periodontology · doi:10.4103/0972-124x.82255 · Cited by 29
Therapeutic Potential of Regulatory T cells in Autoimmune Disorders
Fessler, J., Felber, A., Duftner, C., & Dejaco, C. (2013) · BioDrugs · doi:10.1007/s40259-013-0026-5 · Cited by 31
Chen, B., Zeng, Z., Wu, X., Minhu, C., Li, M., Xiang, G., Baili, C., & Hu, P. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0027-9 · Cited by 27
Interleukin-23 as a potential therapeutic target for rheumatoid arthritis
Rong, C., Hu, W. M., Wu, F., Cao, X.-J., & Chen, F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1109-6 · Cited by 31
Sender, L. Y., Sutter, K., Suezer, Y., Radeke, H. H., Kalinke, U., & Waibler, Z. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.008 · Cited by 27
Co-Culture of Human Bronchial Fibroblasts and CD4+ T Cells Increases Th17 Cytokine Signature
Loubaki, L., Salem, I. H., Fakhfakh, R., Jacques, É., Plante, S., Boisvert, M., Aoudjit, F., & Chakir, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081983 · Cited by 29
Park, S. Y., Lee, S. W., Lee, W. S., Rhim, B. Y., Lee, S. J., Kwon, S., Hong, K. W., & Kim, C. D. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.017 · Cited by 28
Acinetobacter baumanniiInfection and IL-17 Mediated Immunity
Yan, Z., Yang, J., Hu, R., Hu, X., & Chen, K. (2016) · Mediators of Inflammation · doi:10.1155/2016/9834020 · Cited by 29
Both IFN ‐γ and IL ‐17 are required for the development of severe autoimmune gastritis
Tu, E., Ang, D. K. Y., Bellingham, S. A., Hogan, T. V., Teng, M. W. L., Smyth, M. J., Hill, A. F., & van Driel, I. R. (2012) · European Journal of Immunology · doi:10.1002/eji.201142341 · Cited by 28
Wada, H., Miyoshi, J., Kuronuma, S., Nishinarita, Y., Oguri, N., Hibi, N., Takeuchi, O., Akimoto, Y., Lee, S. T. M., Matsuura, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39491-x · Cited by 35
Samson, M., Lakomy, D., Audia, S., & Bonnotte, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.12.020 · Cited by 31
Collins, L. E., DeCourcey, J., Rochfort, K. D., Kristek, M., & Loscher, C. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00691 · Cited by 29
Danesi, F., Philpott, M., Hüebner, C., Bordoni, A., & Ferguson, L. R. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.01.001 · Cited by 27
Inflammatory Monocyte Recruitment Is Regulated by Interleukin-23 during Systemic Bacterial Infection
Indramohan, M., Sieve, A. N., Break, T. J., & Berg, R. E. (2012) · Infection and Immunity · doi:10.1128/iai.00589-12 · Cited by 26
Dowell, A. C., Cobby, E., Wen, K., Devall, A., During, V., Anderson, J., James, N. D., Cheng, K. K., Zeegers, M. P., Bryan, R. T., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184841 · Cited by 32
γδTCR regulates production of interleukin-27 by neutrophils and attenuates inflammatory arthritis
Bouchareychas, L., Grössinger, E. M., Kang, M., & Adamopoulos, I. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-25988-3 · Cited by 26
Rajaii, F., McCoy, A. N., & Smith, T. J. (2014) · Expert Review of Ophthalmology · doi:10.1586/17469899.2014.917960 · Cited by 30
Petro, T. M. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2004.10.014 · Cited by 28
Blander, J. M., Torchinsky, M. B., & Campisi, L. (2012) · Immunologic Research · doi:10.1007/s12026-012-8311-9 · Cited by 25
IL-23 orchestrating immune cell activation in arthritis
Najm, A., & McInnes, I. B. (2021) · Rheumatology · doi:10.1093/rheumatology/keab266 · Cited by 25
Metadata
- Authors
- Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J.
- Affiliations
- 1Discovery Research, DNAX Research Inc., Palo Alto, CA 94304
- 2Experimental Pathology and Pharmacology, DNAX Research Inc., Palo Alto, CA 94304
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-12-08
- Volume
- 198
- Issue
- 12
- Pages
- 1951-1957
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194162
- OpenAlex
- W2116828514
- Cited by
- 1,669
- References
- 32
- Citations by year
- 2026: 18 · 2025: 14 · 2024: 27 · 2023: 31 · 2022: 34 · 2021: 42 · 2020: 46 · 2019: 53 · 2018: 53 · 2017: 56 · 2016: 55 · 2015: 76 · 2014: 75 · 2013: 98 · 2012: 105
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-23, IL-12, collagen-induced arthritis, IL-17-producing T cells, CD4+ T cells, Th1 cells, IL23R, bone pathology, inflammatory cytokines, TNF-α, IL-1β, interleukin-6, IL-17
- MeSH terms
- Animals, Arthritis, Experimental, Female, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, T-Lymphocytes, Tumor Necrosis Factor-alpha, Interleukin-12, Interleukin-17, Collagen Type II, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.